Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Unpacking Wellbeing in the Workplace

Wellbeing is a vague term that is thrown out often, but why is it important? The CDC states that greater wellbeing levels are associated with “decreased risk of disease, illness, and injury; better immune functioning; speedier recovery; and increased longevity” and that greater wellbeing levels are associated with improved work productivity. So, given the inherent…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from FinFit on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Wellbeing is a vague term that is thrown out often, but why is it important? The CDC states that greater wellbeing levels are associated with “decreased risk of disease, illness, and injury; better immune functioning; speedier recovery; and increased longevity” and that greater wellbeing levels are associated with improved work productivity.

So, given the inherent perks high wellbeing includes for both societal health and the workforce, how can workplaces better address wellbeing and wellness amongst employees?

On today’s episode of SECURE by FinFit, host Charles Lattimer was joined by Daniel Posa, Founder of Workplace Wellbeing Advisors, and Vice Chair of Workplace Wellbeing Initiative at the Global Wellness Institute, to talk about the importance and measurement of wellbeing and wellness in the workplace through her company.

Lattimer and Posa also discussed:

  1. What started Posa’s work on wellbeing and attracted her to that space.
  2. Insights on culturally contextualizing wellbeing and how that is tied to financial stability.
  3. Differences in work-life blend since the pandemic.

Posa explained, “To me, wellbeing is really synonymous with living a fulfilling life. You know, living a life of real quality.” She later stated, “If you can measure wellbeing properly and tie it to the metrics that everybody cares about in a company, whether that’s productivity and retention numbers, healthcare costs, or in a city where you’ve got more economic factors or a country. Then if you can make the case for moving the needle on wellbeing and all the other kind of performance metrics also move in a positive direction, I just felt like that was really the future. Because you can’t just have progress for progress’s sake. You need to also have other people’s lives get better.”

Danielle Posa is Founder of Workplace Wellbeing Advisors, Vice Chair of Workplace Wellbeing Initiative at the Global Wellness Institute, and Founder of The Wellbeing Hacker. She has over 14 years of experience in management consultation. She began her career at Vector Marketing as a Sales Representative and Pilot Sales Manager, and later moved to Gallup Consulting as a Management Consultant, where her interest in wellbeing really began. Posa holds a BS in Marketing and International Business from the University of Maryland, completed and coached multiple self-development courses at Landmark, and has been published on LinkedIn and The Huffington Post.

FinFit

Part of this channel

FinFit

Executive conversations on building a financially resilient workforce.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

CMS Sets $90-$420 Per-Patient Payments for Chronic Care Tech

CMS Sets $90-$420 Per-Patient Payments for Chronic Care Tech

CMS's ACCESS payment model, fully active as of July 2026, pays companies $90 to $420 per Medicare beneficiary per year for technology-supported chronic care tied to outcomes, according to HFMA. The model also requires participants to connect through CMS-designated interoperability networks, and more tech companies than traditional providers have signed on so far.

  • 01CMS ACCESS model provides annual payments of $90 to $420 per Medicare beneficiary for chronic care supported by technology.
  • 02Payments in the ACCESS model range from $90 to $420 per beneficiary per year depending on whether specified outcome targets are met.
  • 03The initiative aims to promote the integration of technology in chronic care management.

Sep 10, 2026

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

AlphaGenome Atlas gives researchers predicted molecular effects for possible DNA changes across the human genome, helping teams prioritize variants for experimental follow-up.

  • 01The Atlas covers roughly nine billion possible single-letter DNA substitutions, according to The Verge.
  • 02Predictions can prioritize research questions but do not establish clinical findings.
  • 03The useful implementation pattern is prediction, study-specific evidence, then validation.

Sep 9, 2026

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI says roughly 10,000 AI agents produced a proposed Navier–Stokes solution in 88 hours, followed by Lean verification. For healthcare and life sciences, the immediate signal is a research workflow built around parallel agents, code execution, provenance and formal checking—not a ready-made clinical simulator.

  • 01OpenAI's result is a proposed proof under review, not a new clinical simulation product.
  • 02The near-term B2B signal is a coordinated research stack combining agents, code and formal verification.
  • 03Healthcare buyers should evaluate provenance, reproducibility, security and cost per validated result.

Sep 9, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512